Clark v. Sanofi-Synthelabo, Inc.

489 F. Supp. 2d 759, 2007 U.S. Dist. LEXIS 19332, 2007 WL 855340
CourtDistrict Court, W.D. Kentucky
DecidedMarch 15, 2007
DocketCivil Action 3:05CV-344-S
StatusPublished
Cited by3 cases

This text of 489 F. Supp. 2d 759 (Clark v. Sanofi-Synthelabo, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Clark v. Sanofi-Synthelabo, Inc., 489 F. Supp. 2d 759, 2007 U.S. Dist. LEXIS 19332, 2007 WL 855340 (W.D. Ky. 2007).

Opinion

MEMORANDUM OPINION

SIMPSON, District Judge.

This matter is before the court on motion of the defendant, Sanofi-Synthelabo, Inc. 1 , for summary judgment in this action alleging age and gender discrimination, retaliation, and wrongful discharge. This action was originally filed in the Jefferson County, Kentucky, Circuit Court. It was removed to this court under our diversity jurisdiction. The plaintiff, Karen Clark, is said to be a resident of Indiana, and the defendant, Sanofi-Synthelabo, Inc. 2 (“Sa-nofi”), a Delaware corporation with its principal place of business in New York.

Sanofi moved for summary judgment (DN 24). Clark moved for leave to file a second amended complaint, seeking to add a wrongful termination claim. The court granted Clark’s motion, and an additional sixty-day discovery period in which to develop the claim. Sanofi then moved for summary judgment as to this additional claim (DN 42). Both motions are presently before the court.

A party moving for summary judgment has the burden of showing that there are no genuine issues of fact and that the movant is entitled to summary judgment as a matter of law. Adickes v. S.H. Kress & Co., 398 U.S. 144, 151-60, 90 S.Ct. 1598, 26 L.Ed.2d 142 (1970); Felix v. Young, 536 F.2d 1126, 1134 (6th Cir.1976). Not every factual dispute between the parties will prevent summary judgment. The disputed facts must be material. They must be facts which, under the substantive law governing the issue, might affect the outcome of the suit. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 106 S.Ct. 2505, 2510, 91 L.Ed.2d 202 (1986). The dispute must also be genuine. The facts must be such that if they were proven at trial, a reasonable jury could return a verdict for the non-moving party. Id. at 2510. The disputed issue does not have to be resolved conclusively in favor of the non-moving party, but that party is required to present some significant probative evidence which makes it necessary to resolve the parties’ differing versions of the dispute at trial. First National Bank of Arizona v. Cities Service Co., 391 U.S. 253, 288-89, 88 S.Ct. 1575, 20 L.Ed.2d 569 (1968). The evidence *761 must be construed in a light most favorable to the party opposing the motion. Bohn Aluminum & Brass Corp. v. Storm King Corp., 303 F.2d 425 (6th Cir.1962).

I. Facts

The following facts are either undisputed or have been taken in the light most favorable to Clark for purposes of summary judgment.

A. Karen Clark

Karen Clark was born in 1956. She is a licensed registered nurse, holding a bachelor of science degree in nursing and a master’s degree in business administration. Beginning in 1995, Clark worked at Jewish Hospital as a cardiovascular nurse specializing in ICU and open heart recovery. In 1998 she began working for Spectra Care as a home-health nurse and later as a cardiopulmonary sales representative selling infusion products to cardiologists and pulmonary specialists. In May of 2000, Sanofi hired Clark as a hospital-based pharmaceutical sales representative. Clark held a position known in the industry as a “specialty rep,” selling primarily cardiovascular drugs such as Primacor, Plavix, Avapro and Avalide to cardiologists in area hospitals.

Clark worked for Sanofi for three and a half years until her resignation on November 1, 2004. She was very successful in sales. In 2001, she achieved 109% of her sales goals and achieved an overall rating of “exceeds expectations” on evaluation by District Manager Mary Ann Brokamp. From October 2002 to September 2003 Clark was in the top 5% of Sanofi sales representatives 3 nationally. In February, 2004, she was ranked third in sales of 200 sales reps nationally and second in the area. In March, 2004, she was ranked first in sales of 200 nationally and first in the area. In June, 2004, she was ranked second in the nation and first in the area.

B. Brett Poole

During her employment with Sanofi, Clark had four direct supervisors: Joe Parrott, Mary Ann Brokamp, Brett Poole, and Sandy Bennett. Brokamp rated Clark’s overall performance for 2001 as “exceeds expectations.” In October 2002, Brett Poole became Clark’s supervisor. Clark and Poole did not develop a good working relationship. In April, 2003 Poole generated a performance evaluation for Clark for the year 2002 giving her an overall performance rating of “meets expectations.” The percentage of a sales rep’s annual raise, if any, was tied directly to the evaluation. Poole had only supervised Clark for two to three months in the year 2002. These evaluations were based in large part on the subjective observations of reps’ immediate supervisors.

Clark confided in another supervisor, Sandra Bennett, about Poole’s behavior. Bennett gave Clark the name and phone number of the of the Human Resources Manager, Jim Luisi, for purposes of making a complaint. Bennett told her that the only thing she knew that Clark could do to rectify the situation was to make a report. She told Clark that Luisi was a man that she could trust. In October 2003, Clark made a verbal complaint to Luisi. She told Luisi that she was uncomfortable being in a car with Poole, that he made comments about women and the sexuality of her co-workers, and that he told his supervisees, including her, to sell off-label 4 *762 and to use unapproved materials. She told Luisi that Poole was asking employees to do things that were illegal, and that she had been told that she would not succeed in management because she was female, a new mom, and from Kentucky. Clark told Poole that she had contacted Luisi about his conduct. Clark contends that she was retaliated against beginning at that time and continuing until her resignation in November of 2004.

C. Positions

A number of changes occurred in the Sanofi sales structure in 2003. First, a special sales force known as the SWAT Team was created. It consisted of seventy-eight individuals who were hired as specialty representatives to target sales of Avapro in specialized and predetermined markets. All but one of these individuals were hired from outside Sanofi. The one individual who came from within the organization was in a position that was being eliminated. He had eighteen years of experience. Sanofi treated him as an “outside hire” due to the elimination of his position, and hired him for a SWAT Team position in a territory for which there were no qualified outside applicants.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Garcimonde-Fisher v. Area203 Marketing, LLC
105 F. Supp. 3d 825 (E.D. Tennessee, 2015)
Lorna Fleming v. Flaherty & Collins, Inc.
529 F. App'x 654 (Sixth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
489 F. Supp. 2d 759, 2007 U.S. Dist. LEXIS 19332, 2007 WL 855340, Counsel Stack Legal Research, https://law.counselstack.com/opinion/clark-v-sanofi-synthelabo-inc-kywd-2007.